Filed Pursuant to Rule 424(b)(3)Registration No. 333-278829
Prospectus Supplement No. 1
(to Prospectus dated April 29, 2024)
Up to 1,682,045 Shares of Common Stock
This prospectus supplement supplements the prospectus, dated April 29, 2024, or the Prospectus, which forms a part of our registration statement on Form S-1 (No. 333-278829). This prospectus supplement is being filed to update and supplement the information in the Prospectus... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 9, 2024
Vital Farms, Inc.
(Exact name of Registrant as Specified in Its Charter)
Delaware
001-39411
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16
Under the Securities Exchange Act of 1934
For the Month of May 2024
SHINHAN FINANCIAL GROUP CO., LTD.
(Translation of registrant's name into English)
20, Sejong-daero 9-gil, Jung-gu, Seoul 04513, Korea (Address of principal executive offices)
Indicate by check mark... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K Local Bounti Corporation For: May 09
-
Form 6-K Inter & Co, Inc. For: Dec 31
-
Form S-8 COLUMBIA BANKING SYSTEM,
-
Form 8-K SB/RH Holdings, LLC For: May 09 Filed by: Spectrum Brands Holdings, Inc.
-
Form 8-K PLUG POWER INC For: May 09
-
Form 6-K Inter & Co, Inc. For: Mar 31
-
Form 8-K Verona Pharma plc For: May 09
-
Form 10-Q BigCommerce Holdings, For: Mar 31
-
Form ARS BJ's Wholesale Club Hold For: Feb 03
-
Form 6-K NexGen Energy Ltd. For: May 09
-
Form 8-K Nuveen Churchill Direct For: May 09
-
Form DEFA14A BJ's Wholesale Club Hold
-
Form 8-K Warner Music Group Corp. For: May 09
-
Form 8-K Enviva Inc. For: May 06
-
Form 10-Q Q32 Bio Inc. For: Mar 31
-
Form 8-K/A Atlantic Union Bankshare For: Apr 01
-
Form 8-K Verona Pharma plc For: May 09
-
Form 10-Q Applied Therapeutics, For: Mar 31
-
Form S-8 COLUMBIA BANKING SYSTEM,
-
Form 8-K Royalty Pharma plc For: May 09
-
Form D newtrul inc.
-
Form S-8 BigCommerce Holdings,
-
Form 10-Q Sterling Check Corp. For: Mar 31
-
Form 8-K COGENT COMMUNICATIONS For: May 09
-
Form 8-K Xometry, Inc. For: May 09
-
Form 8-K Xeris Biopharma Holdings For: May 09
-
Form 10-Q Black Diamond Therapeuti For: Mar 31
-
Form 8-K Shift4 Payments, Inc. For: May 09
-
Form 8-K Atlantic Union Bankshare For: May 07
-
Form 8-K Applied Therapeutics, For: May 09
-
Form 8-K Sterling Check Corp. For: May 09
-
Form 8-K BioXcel Therapeutics, For: May 09
-
Form 10-Q Amylyx Pharmaceuticals, For: Mar 31
-
Form 10-Q BK Technologies Corp For: Mar 31
-
Form 8-K BigCommerce Holdings, For: May 09
-
Form 8-K Mersana Therapeutics, For: May 09
-
Form 10-Q Aura Biosciences, Inc. For: Mar 31
-
Form 8-K Cerence Inc. For: May 09
-
Form 8-K Black Diamond Therapeuti For: May 09
-
Form 6-K ASLAN Pharmaceuticals For: May 09
-
Form 6-K TELUS CORP For: May 09
-
Form 8-K NEXSTAR MEDIA GROUP, For: May 09
-
Form 10-Q Mineralys Therapeutics, For: Mar 31
-
Form 6-K TELUS CORP For: May 09
-
Form 3 CLEANSPARK, INC. For: May 07 Filed by: Monnig Taylor
-
Form 424B5 OptiNose, Inc.
-
Form 8-K IRONWOOD PHARMACEUTICALS For: May 09
-
Form 424B3 Lexeo Therapeutics, Inc.
-
Form S-8 COLUMBIA BANKING SYSTEM,
-
Form 8-K Hyatt Hotels Corp For: May 09